The inequitable distribution of vaccines during the COVID-19 pandemic was the final proof of the need for more home-grown ...
Epidemiologist Michael Osterholm talks about efforts by the Center for Infectious Disease Research and Policy to inform ...
In his new book, 'Fair Doses,' epidemiologist Seth Berkley discusses what went right -- and wrong -- with COVID vaccine ...
Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected ...
A new lipid nanoparticle could make mRNA vaccines more powerful and potentially lower the cost per vaccine dose.
It can take a long time to create a new vaccine and at the same time, there have been many evolutions and new strains of the ...
NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today reported that it has received approval to Start Phase II ...
A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...
A new lipid nanoparticle could make mRNA vaccines more effective and potentially lower the cost per dose. New research suggests an mRNA influenza vaccine delivered with the new particle could generate ...
A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...
Savvy Living: What Seniors Need to Know About This Fall’s Vaccines – The Centers for Disease Control and Prevention (CDC) the overall fall vaccine recommendations for “older adults” resembles last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback